Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex.
about
Cognitive neuropsychology of HIV-associated neurocognitive disordersEffects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy eraHIV Associated Neurocognitive DisordersThe Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Neuropsychological Dysfunction among HIV Infected Drug AbusersThe longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.Neurologic presentations of AIDS.Gene expression patterns associated with neurological disease in human HIV infectionNeurocognitive effects of HIV, hepatitis C, and substance use historyCerebral FDG-PET scanning abnormalities in optimally treated HIV patients.Time-Dependent, HIV-Tat-Induced Perturbation of Human Neurons In Vitro: Towards a Model for the Molecular Pathology of HIV-Associated Neurocognitive DisordersHIV protease inhibitor exposure predicts cerebral small vessel disease.Functional consequences of HIV-associated neuropsychological impairmentAging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's DiseaseGene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment.White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesfMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependenceHuman immunodeficiency virus and depression in primary care: a clinical review.Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesisCentral nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.Subcortical shape and volume abnormalities in an elderly HIV+ cohort.APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometryRecent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients.Updated research nosology for HIV-associated neurocognitive disordersLow levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.Cognitive performance related to HIV-1-infected monocytesEffects of simian immunodeficiency virus on the circadian rhythms of body temperature and gross locomotor activity.Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.MAPPING ABNORMAL SUBCORTICAL BRAIN MORPHOMETRY IN AN ELDERLY HIV+ COHORT.A perspective on the proposal for neurocognitive disorder criteria in DSM-5 as applied to HIV-associated neurocognitive disorders.Care of the human immunodeficiency virus-infected menopausal woman.Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesisRelationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.
P2860
Q22252615-BA97393E-8B63-4BE7-8219-AF719AB2A50BQ24632654-9E13184D-79B8-4330-B95D-43B1F473D5E1Q27023968-5DBCEA6A-FB87-4647-B6A6-F967757D9600Q28066725-40AF33CD-FE31-41B7-8E45-394134DCCFE7Q30234305-5792542F-9E87-46ED-8FB2-6D9E8F6EDADCQ30389107-B0C3D440-02A6-4B90-9E80-613BFA2BA5BFQ30410418-B6427D04-2ABD-4BD1-902D-AC0AC14FC191Q30513406-E74A0285-2F07-47E5-97A0-489C27CF3F9CQ33590337-71E3EA78-767F-450F-B312-363D99063C1AQ33605737-25DD721D-06AC-4CDD-8012-F4C88DF0183EQ33652957-032437C0-A6ED-4F02-B945-6168FECBBF6DQ33728851-B9D5056D-A568-4E46-BFD3-F310EB1C775AQ33734695-2FEC6A7B-45CD-44E2-B4D8-2E80F2E550A0Q33807507-16B7679D-6643-49BF-BA82-12A4394245E7Q33855943-C65A10EA-0BCA-468A-963A-465BA65066D0Q33920647-B68B9A79-308E-4E77-A2FF-04BEFBC1F411Q33936233-25D72007-9C85-4110-85F8-C989EA523DD8Q34091371-EA3511B2-D714-4177-BC67-5BC69D0510ABQ34164664-B73558F8-5F73-48F2-8A43-48B9D3A5F6CDQ34732904-7CA25D0D-2299-4C93-B786-BBF59258DC16Q34797004-E5EE8877-7F9D-4658-97A5-87EA363C7257Q34990422-D00EBD09-80FD-4CF9-8A5D-99BB19B6C23CQ35011997-134DB921-29F9-4A9B-8A80-2680651536D3Q35032667-CF153622-6FA2-4F89-867C-9C82ECD2AE3DQ35164448-14B7DD4E-BC21-48DD-AE45-8081FFBCCDBAQ35241519-8B6145AB-A7F9-4708-BAE9-1C7F598DC154Q35276365-A48E58EF-4B8A-4B62-8D0A-959F66544AE9Q35401301-3BFDB4B7-56E2-4E00-8CD3-4A0BD6744D14Q35627384-2DEDE53A-06DF-4C95-BCB7-E638B4E374F6Q35755761-B1A8036E-6AAE-43A7-BBE1-704224394770Q35822465-BA1E895B-711A-47AC-AAAA-556BC21F43D3Q35909507-255A0FAE-ED11-4C08-85BC-858947321180Q36002666-8BAB2E1C-2F5F-4B82-8977-26363A139812Q36028974-6F2C3B45-2E42-40D9-A563-AEFB0DB10AB4Q36081701-0AC9A4CF-2140-4080-8D53-5F1CC1C3FF27Q36119442-86175698-2320-4609-A2D5-E6E9DE5ECB02Q36128333-B938198F-B270-4879-B398-BCD623EC48C3Q36169735-1CFA831B-A0E9-4D23-94A1-CE664C6CCB04Q36395644-95A1D3D4-60E6-4DC2-BB0F-C2902BBF0AFBQ36617630-6706B1E5-0579-4EB6-8F8C-9348B49FCF1D
P2860
Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evidence for a change in AIDS ...... orms of AIDS dementia complex.
@ast
Evidence for a change in AIDS ...... orms of AIDS dementia complex.
@en
type
label
Evidence for a change in AIDS ...... orms of AIDS dementia complex.
@ast
Evidence for a change in AIDS ...... orms of AIDS dementia complex.
@en
prefLabel
Evidence for a change in AIDS ...... orms of AIDS dementia complex.
@ast
Evidence for a change in AIDS ...... orms of AIDS dementia complex.
@en
P1433
P1476
Evidence for a change in AIDS ...... orms of AIDS dementia complex.
@en
P2093
Bruce J Brew
P407
P478
18 Suppl 1
P577
2004-01-01T00:00:00Z